Put companies on watchlist
Globe Life
ISIN: US37959E1029
WKN: A2PP68
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Globe Life · ISIN: US37959E1029 · PR Newswire (ID: 20241118AQ59067)
18 November 2024 01:00PM

Globe Life Announces New Share Repurchase Authorization


MCKINNEY, Texas, Nov. 18, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE:GL) announced that its Board of Directors has approved an authorization to repurchase up to $1.8 billion of common stock under the Company's existing stock repurchase program. This authorization has no set time period and replaces the previous authorization of $1.3 billion announced on April 29, 2024. 

"We are pleased to announce this new authorization, which demonstrates the Board's well-founded confidence in our business model. Our insurance operations have always been a dependable source of free cash for the parent company, regardless of macroeconomic conditions. Since the onset of our share repurchase program in 1986, we have repurchased approximately $10 billion of common stock," said Matt Darden, Co-Chief Executive Officer. 

Frank Svoboda, Co-Chief Executive Officer added, "We will continue to conduct the buyback program in the same manner as we have historically, utilizing our parent company excess cash flows to repurchase shares over the course of each year absent a more beneficial use of the funds for our shareholders. We remain committed to returning excess capital to shareholders to maximize shareholder value."

Globe Life Inc. is a holding company specializing in life and supplemental health insurance for the middle-income market distributed through multiple channels, including direct to consumer and exclusive and independent agencies.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/globe-life-announces-new-share-repurchase-authorization-302307982.html

SOURCE Globe Life Inc.

Visual performance / price development - Globe Life
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942